Blog

Stock Market

Rights Issue and Record Date: What Investors Get Wrong

Posted by NIFM Editorial Team

A rights issue is one of the few moments in the market where a company hands its existing shareholders something with real value — and where thousands of them quietly let that value expire. The pivot point is a single day: the record date. Get the rights issue and record date sequence right and you can subscribe to discounted shares, sell your entitlement for cash, or step aside on purpose. Get it wrong and your rights entitlement lapses worthless while your stake in the company gets diluted. This guide walks through how the record date, rights entitlement (RE) trading and renunciation actually work in India — and the specific mistakes that cost retail investors money every issue.

23
working days — the new SEBI rights-issue timeline (2025)
317
days — the old FY22–24 average it replaced

What a rights issue is — and why the record date is the hinge

A rights issue is a company raising fresh capital by offering new shares first to people who already own the stock, usually at a discount to the market price. You are not being sold to as a stranger; you are being given a right — the option, not the obligation, to buy more of a company you already hold.

Companies reach for a rights issue when they want money without taking on new lenders or diluting through outside investors. It is a common route for paying down debt, funding an expansion, or shoring up the balance sheet — and because existing owners get first refusal, control stays broadly where it was, provided most shareholders participate. That is the polite version. The blunt version is that a rights issue quietly tests every shareholder’s attention, and the ones who are not paying attention pay for it.

The company fixes an entitlement ratio that decides how many new shares you can buy. A 1:5 ratio means one new share for every five you hold on the record date. The 2026 Sumeet Industries issue, for example, used an 8:25 ratio at an issue price of ₹11.86 per share — eight rights shares for every twenty-five held.

The record date is the eligibility cut-off. Whoever holds the shares in their demat account as of that date receives the rights entitlement. Buy the stock after the record date and you get nothing from this issue. That single dependency is why the record date matters more than the discount headline — it decides whether you are even in the game.

Rights issues are one of several corporate actions a company uses to reward or restructure shareholder value. If you want this foundation built properly rather than pieced together from scattered videos, a structured stock market training course connects rights issues, dividends and buybacks into one mental model instead of isolated trivia.

The record date, ex-date and the 23-day rights issue timeline

Since SEBI's 2025 framework, a rights issue in India moves fast. The overall process was compressed to 23 working days, down from an average of 317 days across FY22–24. For the retail shareholder, the timeline is no longer a lazy multi-month affair — you have a tight, defined window to act.

Two dates anchor everything. The record date sets who is eligible. The ex-date is when the share starts trading without the rights attached — from the ex-date, a new buyer no longer inherits the entitlement. Under the T+1 settlement cycle these sit right next to each other, which is exactly where confusion creeps in.

The RE lands in your demat around T+9 and trades from about T+14

T+1 Draft letter to exchanges T+3 In-principle approval T+9 RE credited to demat T+14 RE trading begins T+23 Allotment and listing

Source: SEBI rights-issue framework, 2025 (indicative working-day schedule)

The subscription window itself runs anywhere from 7 to 30 days. Miss it and there is no reopening the door. This is why treating a rights issue like an IPO you can research at leisure is a mistake — the clock is shorter and the eligibility gate closes on the record date.

Your rights entitlement (RE): the asset most investors ignore

When you qualify on the record date, the company does not send new shares directly. It credits a Rights Entitlement (RE) to your demat account. This RE is a tradable instrument in its own right, sitting under a separate ISIN from your ordinary shares so it never gets confused with them.

Because the RE is an asset, you have three clean choices — and understanding them is the single biggest gap between informed and passive shareholders.

1. Subscribe — pay and get new shares
2. Renounce — sell the RE for cash
3. Lapse — do nothing, lose it

To subscribe, you apply and pay the issue price, usually through ASBA (Application Supported by Blocked Amount), which blocks the money in your bank account and debits it only when shares are allotted. Investors whose banks do not support ASBA use R-WAP, the registrar's web-based application platform. You can apply for your full entitlement or only part of it. You can even apply for additional shares beyond your entitlement — those are allotted at the company’s discretion out of whatever other shareholders leave unsubscribed, so treat any additional allotment as a bonus, not a certainty.

To renounce, you sell the RE on the exchange during its trading window. The RE trades in the Trade-to-Trade (T2T) segment — delivery-only, with no intraday square-off — so treat it as a genuine transfer, not a scalp. A buyer who purchases your RE then applies for the shares in your place.

Want to read corporate actions like a professional, not a headline?

NIFM's smart-investor programme walks through rights issues, bonuses, buybacks and dividends with live Indian examples — bilingual, self-paced, with a certificate on passing the course exam. It is the difference between reacting to a corporate action and planning around it.

Explore the NIFM Certified Smart Investor Course →

The third option is the one nobody chooses on purpose but many end up with by accident. An unactioned RE lapses worthless once the window shuts, and it is extinguished from your demat. You get no shares, no cash, and your ownership percentage falls because the company's total share count has gone up. That is the quiet dilution a rights issue imposes on the inattentive.

Subscribe, renounce or let it lapse: the decision

The right choice depends on your conviction in the company and whether you have cash to deploy — not on the size of the discount alone. Here is the trade-off laid out plainly.

Your choice What you do Cash needed Outcome
Subscribe Apply and pay via ASBA / R-WAP Yes New discounted shares; stake maintained or raised
Renounce Sell the RE in the T2T window No Cash for the RE; stake diluted; cannot re-apply later
Let it lapse Nothing before the deadline No Nothing — RE expires, stake diluted

Notice that renouncing and lapsing both dilute your stake — but only one of them puts money in your pocket. If you are not going to subscribe, selling the RE is almost always better than letting it die. One hard rule to remember: once you renounce, in part or full, you cannot come back and apply for additional rights shares. Renunciation is a one-way door.

This is a different question from whether to tender shares into a buyback, where the company is buying from you, or how a bonus issue or stock split reshapes your holding at zero cost. A rights issue is the only one of these that asks you to bring fresh money to the table.

The mistakes investors make around the record date

Most rights-issue errors are not analytical — they are procedural. The discount looks generous, so people assume the mechanics take care of themselves. They do not. These are the traps that show up every issue.

  • Treating the discount as free money. The share reprices lower after the rights, because new shares enter at a discount. That adjusted level is the theoretical ex-rights price (TERP) — the discount is compensation for dilution, not a gift.
  • Buying the stock after the record date expecting to receive the rights. You will not; eligibility was frozen on the record date.
  • Letting the RE lapse when you had no intention of subscribing. Selling it, even for a small amount, beats zero.
  • Trying to intraday-trade the RE. It sits in the T2T segment — delivery only, no square-off.
  • Missing the subscription deadline because you assumed an IPO-length window. The window can be as short as seven days.

The TERP mechanic is worth seeing once with numbers. Take an illustrative case: a share trading at ₹100 with a 1:5 rights issue priced at ₹60.

₹100
price before (cum-rights)
₹60
rights issue price (the "discount")
₹93.33
TERP after the rights (illustrative)

Illustrative example only. TERP = (cum-rights price × old shares + rights price × new shares) ÷ total shares = (100×5 + 60×1) ÷ 6.

Hold five shares worth ₹500, buy one rights share at ₹60, and you own six shares for ₹560 — a per-share value of ₹93.33. The stock "falling" from ₹100 to around ₹93 on the ex-date is not a loss; it is arithmetic. Investors who panic-sell on that drop misread a mechanical adjustment as bad news. The same clear-eyed reading applies to dividends and how reinvestment compounds a holding over time.

What to do next

When a company you own announces a rights issue, run a short checklist. Confirm the record date and whether you hold shares in demat before it. Note the entitlement ratio and issue price. Mark the RE credit and trading dates, and the subscription deadline. Then make a deliberate choice — subscribe if you have conviction and cash, renounce if you do not, and never let the entitlement lapse by inattention.

The investors who consistently get corporate actions right are not smarter — they simply understand the plumbing. Rights issues, bonuses, buybacks, dividends and the record-date logic underneath them all follow patterns you can learn once and apply for a lifetime of holdings.

Learn corporate actions the structured way

Trusted by 50,000+ learners since 2012 · Hindi + English · Learn at your own pace

Start the NIFM Certified Smart Investor Course

Frequently Asked Questions

What is the record date in a rights issue?

The record date is the cut-off day the company uses to decide who is eligible for the rights issue. If the shares are in your demat account as of the record date, you receive the rights entitlement (RE). Buy the stock after the record date and you will not receive rights from that issue.

What happens if I do nothing in a rights issue?

If you neither subscribe nor sell your rights entitlement before the deadline, the RE lapses worthless and is removed from your demat. You get no new shares and no cash, and your percentage ownership in the company falls because the total number of shares has increased. Doing nothing is the costliest choice.

Can I sell my rights entitlement instead of buying?

Yes. This is called renunciation. Your RE trades on the exchange under a separate ISIN in the Trade-to-Trade segment during a set window, and you can sell it for cash to another investor who then applies for the shares. Once you renounce in part or full, you cannot later apply for additional rights shares.

Why does the share price fall after a rights issue?

Because new shares are issued at a discount, the share reprices to a theoretical ex-rights price (TERP) that blends the old price with the cheaper new shares. It looks like a fall, but for a shareholder who subscribes it is a mechanical adjustment, not a real loss — the discount simply offsets the dilution.

How long does a rights issue take in India now?

Under SEBI's 2025 framework, the overall rights-issue process was shortened to about 23 working days, down from a multi-year average of 317 days. The rights entitlement is typically credited around T+9 and begins trading around T+14, while the subscription window can run anywhere from 7 to 30 days.

Disclaimer: This article is for educational purposes only and does not constitute investment advice. Markets carry risk — please do your own research or consult a qualified financial professional before investing. NIFM provides training and exam preparation; certification exams conducted by regulatory or professional bodies are administered by those bodies independently.

Post Comments